Ronald W. Pero

Chief Tech/Sci/R&D Officer at RezGen5 Ltd.

Health Technology

Consumer Services

Profile

Ronald W.
Pero is a Professor-Emeritus at the University of Lund.
He is also the Chief Scientific Officer at RezGen5 Ltd.
and a Founding Member of Campamed, Inc. and Deep South Partners LLC.
Previously, he was a Founding Member of Oncotelic Therapeutics, Inc. and Optigenex, Inc.

Ronald W. Pero active positions

Companies	Position	Start
RezGen5 Ltd. RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda.	Chief Tech/Sci/R&D Officer	-
University of Lund	Corporate Officer/Principal	-
Campamed, Inc.	Corporate Officer/Principal	-
Deep South Partners LLC	Corporate Officer/Principal	-

All active positions of Ronald W. Pero

Former positions of Ronald W. Pero

Companies	Position	End
OPTIGENEX INC.	Corporate Officer/Principal	-
ONCOTELIC THERAPEUTICS, INC.	Corporate Officer/Principal	-

See the detail of Ronald W. Pero's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ronald W. Pero's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ONCOTELIC THERAPEUTICS, INC.	Health Technology
OPTIGENEX INC.	Health Technology

Private companies	3
RezGen5 Ltd. RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda.	Health Technology
Campamed, Inc.
Deep South Partners LLC

See company connections

Stock Market
Insiders
Ronald W. Pero